Eva Redhe - 05 Oct 2021 Form 4 Insider Report for Enphys Acquisition Corp.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
07 Oct 2021, 20:07:07 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jorge de Pablo, as Attorney-in-Fact

Key filing fact

Eva Redhe filed Form 4 for Enphys Acquisition Corp. on 07 Oct 2021.

Key facts

  • This page summarizes Eva Redhe's Form 4 filing for Enphys Acquisition Corp..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 07 Oct 2021, 20:07.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$60.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NFYS transaction Derivative

Class B Ordinary Shares

Purchase

Transaction value
$60
Shares
+20,000
Change %
Price
$0.003000*
Shares after
20,000
Date
05 Oct 2021
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount
20,000
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

As described in Enphys Acquisition Corp.'s (the "Issuer") registration statement on Form S-1, as amended (File No. 333-257932) (the "Registration Statement") under the heading "Description of Securities," the Class B ordinary shares will automatically convert into the number of shares of Class A ordinary shares at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .